Close
Help




JOURNAL

Clinical Medicine Insights: Oncology

1,056,804 Journal Article Views | Journal Analytics

Paclitaxel as Neoadjuvant Therapy for High Grade Angiosarcoma of the Spleen: a Brief Report and Literature Review

Submit a Paper



Publication Date: 12 Oct 2010

Type: Case Report

Journal: Clinical Medicine Insights: Oncology

Citation: Clinical Medicine Insights: Oncology 2010:4 107-110

doi: 10.4137/CMO.S5329

Abstract

Introduction: Splenic angiosarcoma is a rare tumor with only a few cases reported in the literature. Surgical resection offers the best chance of cure for this aggressive neoplasm but is often precluded by infiltration of the tumor to surrounding critical structures. We report a case of a locally advanced angiosarcoma rendered operable by treatment with Paclitaxel monotherapy.

Case presentation: A 69 year old female presented with a high grade splenic angiosarcoma, considered inoperable due to the extent of local spread. She received three cycles of single agent Paclitaxel and underwent a successful resection of the tumor.

Conclusion: Chemotherapy options for splenic angiosarcoma are not well studied. Paclitaxel as monotherapy is a useful therapeutic option in down staging tumors, facilitating surgical resection and merits further study in clinical trials.



Downloads

PDF  (1.11 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Clinical Medicine Insights: Oncology
This is my second publication with Libertas. I greatly appreciate the attention to details throughout the process, especially the graphical enhancement of my figures. The author interface was very easy to use and the turnaround time on your end was swift and accurate.  I compliment you and your team on your administrative efficiency and high quality of work.
Dr Jimmy T Efird (East Carolina University, Greenville, NC, USA)
More Testimonials

Quick Links


Follow Us We make it easy to find new research papers.